nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Benzphetamine—Diphenhydramine—atopic dermatitis	0.322	1	CrCrCtD
Dextroamphetamine—Pseudoephedrine—IL2—atopic dermatitis	0.00526	0.747	CrCbGaD
Dextroamphetamine—Pseudoephedrine—TNF—atopic dermatitis	0.00177	0.252	CrCbGaD
Dextroamphetamine—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.00124	0.002	CcSEcCtD
Dextroamphetamine—Anxiety—Tacrolimus—atopic dermatitis	0.00124	0.002	CcSEcCtD
Dextroamphetamine—Irritability—Dexamethasone—atopic dermatitis	0.00123	0.00199	CcSEcCtD
Dextroamphetamine—Irritability—Betamethasone—atopic dermatitis	0.00123	0.00199	CcSEcCtD
Dextroamphetamine—Injury—Prednisone—atopic dermatitis	0.00123	0.00197	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.00123	0.00197	CcSEcCtD
Dextroamphetamine—Mood swings—Dexamethasone—atopic dermatitis	0.00122	0.00197	CcSEcCtD
Dextroamphetamine—Mood swings—Betamethasone—atopic dermatitis	0.00122	0.00197	CcSEcCtD
Dextroamphetamine—Dry mouth—Tacrolimus—atopic dermatitis	0.00122	0.00196	CcSEcCtD
Dextroamphetamine—Diarrhoea—Loratadine—atopic dermatitis	0.00119	0.00193	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.00119	0.00192	CcSEcCtD
Dextroamphetamine—Infection—Tacrolimus—atopic dermatitis	0.00118	0.00191	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mometasone—atopic dermatitis	0.00118	0.00191	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mometasone—atopic dermatitis	0.00118	0.00191	CcSEcCtD
Dextroamphetamine—Weight decreased—Hydrocortisone—atopic dermatitis	0.00118	0.00191	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.00118	0.0019	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisolone—atopic dermatitis	0.00117	0.00189	CcSEcCtD
Dextroamphetamine—Tachycardia—Tacrolimus—atopic dermatitis	0.00116	0.00188	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00116	0.00186	CcSEcCtD
Dextroamphetamine—Dizziness—Loratadine—atopic dermatitis	0.00115	0.00186	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00115	0.00186	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.00115	0.00185	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.00114	0.00184	CcSEcCtD
Dextroamphetamine—Anorexia—Tacrolimus—atopic dermatitis	0.00114	0.00183	CcSEcCtD
Dextroamphetamine—Vomiting—Loratadine—atopic dermatitis	0.00111	0.00179	CcSEcCtD
Dextroamphetamine—Affect lability—Prednisone—atopic dermatitis	0.00111	0.00179	CcSEcCtD
Dextroamphetamine—Rash—Loratadine—atopic dermatitis	0.0011	0.00177	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Prednisone—atopic dermatitis	0.0011	0.00177	CcSEcCtD
Dextroamphetamine—Dermatitis—Loratadine—atopic dermatitis	0.0011	0.00177	CcSEcCtD
Dextroamphetamine—Headache—Loratadine—atopic dermatitis	0.00109	0.00176	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.00108	0.00175	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.00108	0.00174	CcSEcCtD
Dextroamphetamine—Insomnia—Tacrolimus—atopic dermatitis	0.00108	0.00174	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Triamcinolone—atopic dermatitis	0.00108	0.00174	CcSEcCtD
Dextroamphetamine—Asthenia—Mometasone—atopic dermatitis	0.00107	0.00173	CcSEcCtD
Dextroamphetamine—Irritability—Prednisone—atopic dermatitis	0.00107	0.00173	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.00107	0.00173	CcSEcCtD
Dextroamphetamine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00107	0.00173	CcSEcCtD
Dextroamphetamine—Mood swings—Prednisone—atopic dermatitis	0.00107	0.00172	CcSEcCtD
Dextroamphetamine—Dyspnoea—Tacrolimus—atopic dermatitis	0.00106	0.00171	CcSEcCtD
Dextroamphetamine—Somnolence—Tacrolimus—atopic dermatitis	0.00106	0.00171	CcSEcCtD
Dextroamphetamine—Sweating—Methylprednisolone—atopic dermatitis	0.00105	0.00169	CcSEcCtD
Dextroamphetamine—Dyspepsia—Tacrolimus—atopic dermatitis	0.00105	0.00169	CcSEcCtD
Dextroamphetamine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00104	0.00167	CcSEcCtD
Dextroamphetamine—Nausea—Loratadine—atopic dermatitis	0.00104	0.00167	CcSEcCtD
Dextroamphetamine—Decreased appetite—Tacrolimus—atopic dermatitis	0.00104	0.00167	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00103	0.00166	CcSEcCtD
Dextroamphetamine—Fatigue—Tacrolimus—atopic dermatitis	0.00103	0.00166	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mometasone—atopic dermatitis	0.00103	0.00165	CcSEcCtD
Dextroamphetamine—Constipation—Tacrolimus—atopic dermatitis	0.00102	0.00164	CcSEcCtD
Dextroamphetamine—Weight decreased—Betamethasone—atopic dermatitis	0.00101	0.00163	CcSEcCtD
Dextroamphetamine—Weight decreased—Dexamethasone—atopic dermatitis	0.00101	0.00163	CcSEcCtD
Dextroamphetamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000998	0.00161	CcSEcCtD
Dextroamphetamine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000989	0.00159	CcSEcCtD
Dextroamphetamine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000988	0.00159	CcSEcCtD
Dextroamphetamine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000983	0.00158	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000982	0.00158	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000982	0.00158	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000977	0.00157	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Betamethasone—atopic dermatitis	0.000977	0.00157	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000975	0.00157	CcSEcCtD
Dextroamphetamine—Vomiting—Mometasone—atopic dermatitis	0.000953	0.00154	CcSEcCtD
Dextroamphetamine—Urticaria—Tacrolimus—atopic dermatitis	0.000947	0.00153	CcSEcCtD
Dextroamphetamine—Rash—Mometasone—atopic dermatitis	0.000945	0.00152	CcSEcCtD
Dextroamphetamine—Dermatitis—Mometasone—atopic dermatitis	0.000944	0.00152	CcSEcCtD
Dextroamphetamine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000943	0.00152	CcSEcCtD
Dextroamphetamine—Body temperature increased—Tacrolimus—atopic dermatitis	0.000943	0.00152	CcSEcCtD
Dextroamphetamine—Headache—Mometasone—atopic dermatitis	0.000939	0.00151	CcSEcCtD
Dextroamphetamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000932	0.0015	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000917	0.018	CbGpPWpGaD
Dextroamphetamine—Erectile dysfunction—Prednisone—atopic dermatitis	0.000896	0.00144	CcSEcCtD
Dextroamphetamine—Nausea—Mometasone—atopic dermatitis	0.00089	0.00143	CcSEcCtD
Dextroamphetamine—Weight decreased—Prednisone—atopic dermatitis	0.000881	0.00142	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000879	0.00142	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—CCL17—atopic dermatitis	0.000866	0.017	CbGpPWpGaD
Dextroamphetamine—Depression—Prednisone—atopic dermatitis	0.000865	0.00139	CcSEcCtD
Dextroamphetamine—Asthenia—Tacrolimus—atopic dermatitis	0.000856	0.00138	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000855	0.00138	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisolone—atopic dermatitis	0.000853	0.00137	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisone—atopic dermatitis	0.000851	0.00137	CcSEcCtD
Dextroamphetamine—Angioedema—Hydrocortisone—atopic dermatitis	0.000833	0.00134	CcSEcCtD
Dextroamphetamine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000816	0.00132	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisolone—atopic dermatitis	0.000809	0.0013	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisolone—atopic dermatitis	0.000806	0.0013	CcSEcCtD
Dextroamphetamine—Convulsion—Hydrocortisone—atopic dermatitis	0.00079	0.00127	CcSEcCtD
Dextroamphetamine—Dizziness—Tacrolimus—atopic dermatitis	0.000789	0.00127	CcSEcCtD
Dextroamphetamine—Hypertension—Hydrocortisone—atopic dermatitis	0.000787	0.00127	CcSEcCtD
Dextroamphetamine—Angioedema—Triamcinolone—atopic dermatitis	0.000784	0.00126	CcSEcCtD
Dextroamphetamine—Angioedema—Methylprednisolone—atopic dermatitis	0.000782	0.00126	CcSEcCtD
Dextroamphetamine—Anxiety—Hydrocortisone—atopic dermatitis	0.000773	0.00125	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000762	0.00123	CcSEcCtD
Dextroamphetamine—Vomiting—Tacrolimus—atopic dermatitis	0.000758	0.00122	CcSEcCtD
Dextroamphetamine—Rash—Tacrolimus—atopic dermatitis	0.000752	0.00121	CcSEcCtD
Dextroamphetamine—Dermatitis—Tacrolimus—atopic dermatitis	0.000751	0.00121	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000747	0.0146	CbGpPWpGaD
Dextroamphetamine—Headache—Tacrolimus—atopic dermatitis	0.000747	0.0012	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000744	0.0012	CcSEcCtD
Dextroamphetamine—Convulsion—Triamcinolone—atopic dermatitis	0.000744	0.0012	CcSEcCtD
Dextroamphetamine—Tachycardia—Prednisolone—atopic dermatitis	0.000743	0.0012	CcSEcCtD
Dextroamphetamine—Convulsion—Methylprednisolone—atopic dermatitis	0.000742	0.0012	CcSEcCtD
Dextroamphetamine—Hypertension—Triamcinolone—atopic dermatitis	0.000741	0.00119	CcSEcCtD
Dextroamphetamine—Hypertension—Methylprednisolone—atopic dermatitis	0.000739	0.00119	CcSEcCtD
Dextroamphetamine—Infection—Hydrocortisone—atopic dermatitis	0.000739	0.00119	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000736	0.00119	CcSEcCtD
Dextroamphetamine—Anxiety—Methylprednisolone—atopic dermatitis	0.000727	0.00117	CcSEcCtD
Dextroamphetamine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000726	0.00117	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000719	0.00116	CcSEcCtD
Dextroamphetamine—Dry mouth—Triamcinolone—atopic dermatitis	0.000715	0.00115	CcSEcCtD
Dextroamphetamine—Angioedema—Dexamethasone—atopic dermatitis	0.000712	0.00115	CcSEcCtD
Dextroamphetamine—Angioedema—Betamethasone—atopic dermatitis	0.000712	0.00115	CcSEcCtD
Dextroamphetamine—Anorexia—Hydrocortisone—atopic dermatitis	0.000709	0.00114	CcSEcCtD
Dextroamphetamine—Nausea—Tacrolimus—atopic dermatitis	0.000708	0.00114	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.0007	0.00113	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000699	0.00113	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—CCL11—atopic dermatitis	0.000698	0.0137	CbGpPWpGaD
Dextroamphetamine—Infection—Triamcinolone—atopic dermatitis	0.000696	0.00112	CcSEcCtD
Dextroamphetamine—Infection—Methylprednisolone—atopic dermatitis	0.000694	0.00112	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisolone—atopic dermatitis	0.000689	0.00111	CcSEcCtD
Dextroamphetamine—Tachycardia—Triamcinolone—atopic dermatitis	0.000684	0.0011	CcSEcCtD
Dextroamphetamine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000682	0.0011	CcSEcCtD
Dextroamphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000678	0.0133	CbGpPWpGaD
Dextroamphetamine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000677	0.00109	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000676	0.00109	CcSEcCtD
Dextroamphetamine—Convulsion—Dexamethasone—atopic dermatitis	0.000675	0.00109	CcSEcCtD
Dextroamphetamine—Convulsion—Betamethasone—atopic dermatitis	0.000675	0.00109	CcSEcCtD
Dextroamphetamine—Insomnia—Hydrocortisone—atopic dermatitis	0.000673	0.00108	CcSEcCtD
Dextroamphetamine—Hypertension—Betamethasone—atopic dermatitis	0.000672	0.00108	CcSEcCtD
Dextroamphetamine—Hypertension—Dexamethasone—atopic dermatitis	0.000672	0.00108	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000666	0.0131	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000666	0.0131	CbGpPWpGaD
Dextroamphetamine—Anxiety—Dexamethasone—atopic dermatitis	0.000661	0.00106	CcSEcCtD
Dextroamphetamine—Anxiety—Betamethasone—atopic dermatitis	0.000661	0.00106	CcSEcCtD
Dextroamphetamine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000655	0.00106	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000653	0.0128	CbGpPWpGaD
Dextroamphetamine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000647	0.00104	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000642	0.00104	CcSEcCtD
Dextroamphetamine—Fatigue—Hydrocortisone—atopic dermatitis	0.000641	0.00103	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000636	0.00102	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000636	0.00102	CcSEcCtD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000634	0.0124	CbGpPWpGaD
Dextroamphetamine—Insomnia—Triamcinolone—atopic dermatitis	0.000634	0.00102	CcSEcCtD
Dextroamphetamine—Insomnia—Methylprednisolone—atopic dermatitis	0.000632	0.00102	CcSEcCtD
Dextroamphetamine—Infection—Betamethasone—atopic dermatitis	0.000631	0.00102	CcSEcCtD
Dextroamphetamine—Infection—Dexamethasone—atopic dermatitis	0.000631	0.00102	CcSEcCtD
Dextroamphetamine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000624	0.00101	CcSEcCtD
Dextroamphetamine—Agitation—Prednisone—atopic dermatitis	0.000623	0.001	CcSEcCtD
Dextroamphetamine—Tachycardia—Dexamethasone—atopic dermatitis	0.00062	0.001	CcSEcCtD
Dextroamphetamine—Tachycardia—Betamethasone—atopic dermatitis	0.00062	0.001	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisone—atopic dermatitis	0.00062	0.000999	CcSEcCtD
Dextroamphetamine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000617	0.000994	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000615	0.000992	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000614	0.00099	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000614	0.00099	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000608	0.000981	CcSEcCtD
Dextroamphetamine—Anorexia—Dexamethasone—atopic dermatitis	0.000606	0.000977	CcSEcCtD
Dextroamphetamine—Anorexia—Betamethasone—atopic dermatitis	0.000606	0.000977	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisolone—atopic dermatitis	0.000605	0.000975	CcSEcCtD
Dextroamphetamine—Fatigue—Triamcinolone—atopic dermatitis	0.000604	0.000973	CcSEcCtD
Dextroamphetamine—Fatigue—Methylprednisolone—atopic dermatitis	0.000603	0.000971	CcSEcCtD
Dextroamphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000601	0.0118	CbGpPWpGaD
Dextroamphetamine—Urticaria—Hydrocortisone—atopic dermatitis	0.000591	0.000953	CcSEcCtD
Dextroamphetamine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000588	0.000948	CcSEcCtD
Dextroamphetamine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000588	0.000948	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisone—atopic dermatitis	0.000588	0.000947	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisone—atopic dermatitis	0.000586	0.000944	CcSEcCtD
Dextroamphetamine—Anxiety—Prednisone—atopic dermatitis	0.000575	0.000927	CcSEcCtD
Dextroamphetamine—Insomnia—Betamethasone—atopic dermatitis	0.000575	0.000927	CcSEcCtD
Dextroamphetamine—Insomnia—Dexamethasone—atopic dermatitis	0.000575	0.000927	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000571	0.000921	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—CCR3—atopic dermatitis	0.000569	0.0112	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000561	0.000905	CcSEcCtD
Dextroamphetamine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000559	0.000902	CcSEcCtD
Dextroamphetamine—Dyspepsia—Betamethasone—atopic dermatitis	0.000559	0.000902	CcSEcCtD
Dextroamphetamine—Urticaria—Triamcinolone—atopic dermatitis	0.000556	0.000897	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCL22—atopic dermatitis	0.000556	0.0109	CbGpPWpGaD
Dextroamphetamine—Urticaria—Methylprednisolone—atopic dermatitis	0.000555	0.000895	CcSEcCtD
Dextroamphetamine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000554	0.000893	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000553	0.000892	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000552	0.000891	CcSEcCtD
Dextroamphetamine—Decreased appetite—Dexamethasone—atopic dermatitis	0.000552	0.000891	CcSEcCtD
Dextroamphetamine—Decreased appetite—Betamethasone—atopic dermatitis	0.000552	0.000891	CcSEcCtD
Dextroamphetamine—Infection—Prednisone—atopic dermatitis	0.00055	0.000886	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000549	0.000884	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000549	0.000884	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000548	0.000883	CcSEcCtD
Dextroamphetamine—Fatigue—Betamethasone—atopic dermatitis	0.000548	0.000883	CcSEcCtD
Dextroamphetamine—Fatigue—Dexamethasone—atopic dermatitis	0.000548	0.000883	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000546	0.0107	CbGpPWpGaD
Dextroamphetamine—Tachycardia—Prednisone—atopic dermatitis	0.00054	0.000871	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000535	0.000862	CcSEcCtD
Dextroamphetamine—Asthenia—Hydrocortisone—atopic dermatitis	0.000534	0.00086	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000528	0.0103	CbGpPWpGaD
Dextroamphetamine—Anorexia—Prednisone—atopic dermatitis	0.000528	0.00085	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.00052	0.000838	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.00052	0.000838	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000516	0.000832	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000515	0.00083	CcSEcCtD
Dextroamphetamine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000509	0.00082	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—NPS—atopic dermatitis	0.000507	0.00994	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—TAC1—atopic dermatitis	0.000507	0.00994	CbGpPWpGaD
Dextroamphetamine—Urticaria—Dexamethasone—atopic dermatitis	0.000505	0.000814	CcSEcCtD
Dextroamphetamine—Urticaria—Betamethasone—atopic dermatitis	0.000505	0.000814	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisolone—atopic dermatitis	0.000504	0.000812	CcSEcCtD
Dextroamphetamine—Asthenia—Triamcinolone—atopic dermatitis	0.000503	0.00081	CcSEcCtD
Dextroamphetamine—Body temperature increased—Betamethasone—atopic dermatitis	0.000502	0.00081	CcSEcCtD
Dextroamphetamine—Body temperature increased—Dexamethasone—atopic dermatitis	0.000502	0.00081	CcSEcCtD
Dextroamphetamine—Abdominal pain—Betamethasone—atopic dermatitis	0.000502	0.00081	CcSEcCtD
Dextroamphetamine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000502	0.00081	CcSEcCtD
Dextroamphetamine—Asthenia—Methylprednisolone—atopic dermatitis	0.000501	0.000808	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisone—atopic dermatitis	0.000501	0.000807	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000497	0.00975	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCL27—atopic dermatitis	0.000496	0.00971	CbGpPWpGaD
Dextroamphetamine—Dizziness—Hydrocortisone—atopic dermatitis	0.000492	0.000793	CcSEcCtD
Dextroamphetamine—Dyspepsia—Prednisone—atopic dermatitis	0.000487	0.000785	CcSEcCtD
Dextroamphetamine—SLC6A2—Monoamine Transport—IL1B—atopic dermatitis	0.000483	0.00946	CbGpPWpGaD
Dextroamphetamine—Decreased appetite—Prednisone—atopic dermatitis	0.000481	0.000776	CcSEcCtD
Dextroamphetamine—Rash—Prednisolone—atopic dermatitis	0.00048	0.000774	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisolone—atopic dermatitis	0.00048	0.000773	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000478	0.000771	CcSEcCtD
Dextroamphetamine—Fatigue—Prednisone—atopic dermatitis	0.000477	0.000769	CcSEcCtD
Dextroamphetamine—Headache—Prednisolone—atopic dermatitis	0.000477	0.000769	CcSEcCtD
Dextroamphetamine—Constipation—Prednisone—atopic dermatitis	0.000473	0.000763	CcSEcCtD
Dextroamphetamine—Vomiting—Hydrocortisone—atopic dermatitis	0.000473	0.000762	CcSEcCtD
Dextroamphetamine—Rash—Hydrocortisone—atopic dermatitis	0.000469	0.000756	CcSEcCtD
Dextroamphetamine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000469	0.000755	CcSEcCtD
Dextroamphetamine—Headache—Hydrocortisone—atopic dermatitis	0.000466	0.000751	CcSEcCtD
Dextroamphetamine—Dizziness—Triamcinolone—atopic dermatitis	0.000463	0.000747	CcSEcCtD
Dextroamphetamine—Dizziness—Methylprednisolone—atopic dermatitis	0.000462	0.000745	CcSEcCtD
Dextroamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000458	0.00897	CbGpPWpGaD
Dextroamphetamine—Asthenia—Dexamethasone—atopic dermatitis	0.000456	0.000735	CcSEcCtD
Dextroamphetamine—Asthenia—Betamethasone—atopic dermatitis	0.000456	0.000735	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000454	0.00891	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000453	0.00073	CcSEcCtD
Dextroamphetamine—Nausea—Prednisolone—atopic dermatitis	0.000452	0.000729	CcSEcCtD
Dextroamphetamine—Vomiting—Triamcinolone—atopic dermatitis	0.000445	0.000718	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCL17—atopic dermatitis	0.000444	0.00871	CbGpPWpGaD
Dextroamphetamine—Vomiting—Methylprednisolone—atopic dermatitis	0.000444	0.000716	CcSEcCtD
Dextroamphetamine—Nausea—Hydrocortisone—atopic dermatitis	0.000442	0.000712	CcSEcCtD
Dextroamphetamine—Rash—Triamcinolone—atopic dermatitis	0.000442	0.000712	CcSEcCtD
Dextroamphetamine—Dermatitis—Triamcinolone—atopic dermatitis	0.000441	0.000711	CcSEcCtD
Dextroamphetamine—Rash—Methylprednisolone—atopic dermatitis	0.000441	0.00071	CcSEcCtD
Dextroamphetamine—Dermatitis—Methylprednisolone—atopic dermatitis	0.00044	0.00071	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisone—atopic dermatitis	0.00044	0.000709	CcSEcCtD
Dextroamphetamine—Headache—Triamcinolone—atopic dermatitis	0.000439	0.000707	CcSEcCtD
Dextroamphetamine—Headache—Methylprednisolone—atopic dermatitis	0.000438	0.000706	CcSEcCtD
Dextroamphetamine—Abdominal pain—Prednisone—atopic dermatitis	0.000438	0.000705	CcSEcCtD
Dextroamphetamine—Body temperature increased—Prednisone—atopic dermatitis	0.000438	0.000705	CcSEcCtD
Dextroamphetamine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000435	0.000701	CcSEcCtD
Dextroamphetamine—Diarrhoea—Betamethasone—atopic dermatitis	0.000435	0.000701	CcSEcCtD
Dextroamphetamine—SLC6A3—Monoamine Transport—IL1B—atopic dermatitis	0.000428	0.00838	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000427	0.00836	CbGpPWpGaD
Dextroamphetamine—Dizziness—Dexamethasone—atopic dermatitis	0.00042	0.000677	CcSEcCtD
Dextroamphetamine—Dizziness—Betamethasone—atopic dermatitis	0.00042	0.000677	CcSEcCtD
Dextroamphetamine—Nausea—Triamcinolone—atopic dermatitis	0.000416	0.000671	CcSEcCtD
Dextroamphetamine—Nausea—Methylprednisolone—atopic dermatitis	0.000415	0.000669	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000409	0.00802	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Prednisone—atopic dermatitis	0.000408	0.000657	CcSEcCtD
Dextroamphetamine—Vomiting—Dexamethasone—atopic dermatitis	0.000404	0.000651	CcSEcCtD
Dextroamphetamine—Vomiting—Betamethasone—atopic dermatitis	0.000404	0.000651	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000402	0.00788	CbGpPWpGaD
Dextroamphetamine—Rash—Dexamethasone—atopic dermatitis	0.000401	0.000646	CcSEcCtD
Dextroamphetamine—Rash—Betamethasone—atopic dermatitis	0.000401	0.000646	CcSEcCtD
Dextroamphetamine—Dermatitis—Dexamethasone—atopic dermatitis	0.0004	0.000645	CcSEcCtD
Dextroamphetamine—Dermatitis—Betamethasone—atopic dermatitis	0.0004	0.000645	CcSEcCtD
Dextroamphetamine—Headache—Betamethasone—atopic dermatitis	0.000398	0.000642	CcSEcCtD
Dextroamphetamine—Headache—Dexamethasone—atopic dermatitis	0.000398	0.000642	CcSEcCtD
Dextroamphetamine—Asthenia—Prednisone—atopic dermatitis	0.000397	0.00064	CcSEcCtD
Dextroamphetamine—Diarrhoea—Prednisone—atopic dermatitis	0.000379	0.00061	CcSEcCtD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000378	0.00741	CbGpPWpGaD
Dextroamphetamine—Nausea—Betamethasone—atopic dermatitis	0.000378	0.000609	CcSEcCtD
Dextroamphetamine—Nausea—Dexamethasone—atopic dermatitis	0.000378	0.000609	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisone—atopic dermatitis	0.000366	0.00059	CcSEcCtD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00036	0.00705	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000358	0.00702	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—FCER2—atopic dermatitis	0.000353	0.00692	CbGpPWpGaD
Dextroamphetamine—Vomiting—Prednisone—atopic dermatitis	0.000352	0.000567	CcSEcCtD
Dextroamphetamine—SLC6A2—Monoamine Transport—TNF—atopic dermatitis	0.00035	0.00686	CbGpPWpGaD
Dextroamphetamine—Rash—Prednisone—atopic dermatitis	0.000349	0.000563	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisone—atopic dermatitis	0.000349	0.000562	CcSEcCtD
Dextroamphetamine—Headache—Prednisone—atopic dermatitis	0.000347	0.000559	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000346	0.00678	CbGpPWpGaD
Dextroamphetamine—Nausea—Prednisone—atopic dermatitis	0.000329	0.00053	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL22—atopic dermatitis	0.000328	0.00644	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000322	0.0063	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000321	0.00629	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00032	0.00626	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—NFKBIA—atopic dermatitis	0.000313	0.00613	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CCR5—atopic dermatitis	0.000312	0.00611	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Monoamine Transport—TNF—atopic dermatitis	0.00031	0.00608	CbGpPWpGaD
Dextroamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000308	0.00604	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL27—atopic dermatitis	0.000293	0.00574	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCR3—atopic dermatitis	0.000292	0.00572	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000288	0.00564	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000287	0.00562	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—NPS—atopic dermatitis	0.000287	0.00562	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000285	0.00558	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000281	0.00551	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL22—atopic dermatitis	0.000274	0.00537	CbGpPWpGaD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000273	0.00535	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—IL5—atopic dermatitis	0.000266	0.00522	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL17—atopic dermatitis	0.000263	0.00514	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—NPS—atopic dermatitis	0.00026	0.0051	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—TAC1—atopic dermatitis	0.00026	0.0051	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000256	0.00501	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000255	0.005	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—NPS—atopic dermatitis	0.000254	0.00499	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000254	0.00499	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000248	0.00485	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL27—atopic dermatitis	0.000244	0.00479	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL22—atopic dermatitis	0.000243	0.00477	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL5—atopic dermatitis	0.000242	0.00474	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000234	0.00459	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000233	0.00456	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000232	0.00454	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000228	0.00446	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000228	0.00446	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000227	0.00445	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000226	0.00443	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—NPS—atopic dermatitis	0.000226	0.00443	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—CXCL8—atopic dermatitis	0.000223	0.00437	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000221	0.00432	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL17—atopic dermatitis	0.000219	0.00429	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL27—atopic dermatitis	0.000217	0.00425	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CMA1—atopic dermatitis	0.000212	0.00415	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL11—atopic dermatitis	0.000212	0.00415	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000206	0.00404	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000206	0.00404	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000202	0.00396	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000202	0.00396	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT6—atopic dermatitis	0.000199	0.0039	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000196	0.00384	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000196	0.00383	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL17—atopic dermatitis	0.000195	0.00381	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000193	0.00378	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000189	0.0037	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000189	0.00369	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000178	0.00348	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL11—atopic dermatitis	0.000177	0.00346	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000176	0.00345	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCR3—atopic dermatitis	0.000173	0.00338	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000171	0.00336	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000168	0.0033	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000168	0.0033	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000168	0.00329	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000165	0.00324	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCR5—atopic dermatitis	0.00016	0.00314	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL11—atopic dermatitis	0.000157	0.00307	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000157	0.00307	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TAC1—atopic dermatitis	0.000154	0.00301	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NPS—atopic dermatitis	0.000154	0.00301	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000151	0.00295	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00015	0.00293	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00015	0.00293	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000147	0.00288	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCR3—atopic dermatitis	0.000144	0.00282	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL5—atopic dermatitis	0.000143	0.0028	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL22—atopic dermatitis	0.000141	0.00276	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000139	0.00272	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCL27—atopic dermatitis	0.000138	0.0027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000134	0.00262	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—NPS—atopic dermatitis	0.000128	0.00251	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—TAC1—atopic dermatitis	0.000128	0.00251	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCR3—atopic dermatitis	0.000128	0.00251	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCR3—atopic dermatitis	0.000126	0.00247	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL27—atopic dermatitis	0.000125	0.00246	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL22—atopic dermatitis	0.000125	0.00245	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCL27—atopic dermatitis	0.000123	0.0024	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000122	0.00239	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000121	0.00237	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000119	0.00232	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000115	0.00225	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—TAC1—atopic dermatitis	0.000114	0.00223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—NPS—atopic dermatitis	0.000114	0.00223	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000113	0.00221	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL17—atopic dermatitis	0.000112	0.0022	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCR3—atopic dermatitis	0.000112	0.00219	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL27—atopic dermatitis	0.000111	0.00218	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000107	0.0021	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000107	0.00209	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL5—atopic dermatitis	0.000105	0.00206	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000104	0.00203	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000102	0.002	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—IL2—atopic dermatitis	0.000102	0.002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL10—atopic dermatitis	0.000102	0.00199	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL17—atopic dermatitis	9.99e-05	0.00196	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NGF—atopic dermatitis	9.72e-05	0.0019	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CXCL8—atopic dermatitis	9.67e-05	0.0019	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCR5—atopic dermatitis	9.45e-05	0.00185	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL2—atopic dermatitis	9.25e-05	0.00181	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.2e-05	0.0018	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL11—atopic dermatitis	9.06e-05	0.00178	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL10—atopic dermatitis	9.03e-05	0.00177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FCER2—atopic dermatitis	8.94e-05	0.00175	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL5—atopic dermatitis	8.75e-05	0.00172	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL22—atopic dermatitis	8.31e-05	0.00163	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR3—atopic dermatitis	8.13e-05	0.00159	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL11—atopic dermatitis	8.05e-05	0.00158	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NFKBIA—atopic dermatitis	8.01e-05	0.00157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FCER2—atopic dermatitis	7.94e-05	0.00156	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCR5—atopic dermatitis	7.89e-05	0.00155	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL5—atopic dermatitis	7.78e-05	0.00152	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	7.59e-05	0.00149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL27—atopic dermatitis	7.4e-05	0.00145	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR3—atopic dermatitis	7.39e-05	0.00145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL22—atopic dermatitis	7.38e-05	0.00145	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—NPS—atopic dermatitis	7.25e-05	0.00142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TAC1—atopic dermatitis	7.25e-05	0.00142	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR3—atopic dermatitis	7.23e-05	0.00142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCR3—atopic dermatitis	7.11e-05	0.00139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCR5—atopic dermatitis	7.01e-05	0.00137	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL5—atopic dermatitis	6.74e-05	0.00132	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.72e-05	0.00132	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL17—atopic dermatitis	6.64e-05	0.0013	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TAC1—atopic dermatitis	6.58e-05	0.00129	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—NPS—atopic dermatitis	6.58e-05	0.00129	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL27—atopic dermatitis	6.58e-05	0.00129	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR3—atopic dermatitis	6.56e-05	0.00129	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCR3—atopic dermatitis	6.46e-05	0.00127	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TAC1—atopic dermatitis	6.44e-05	0.00126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—NPS—atopic dermatitis	6.44e-05	0.00126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCR3—atopic dermatitis	6.32e-05	0.00124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.26e-05	0.00123	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL5—atopic dermatitis	6.12e-05	0.0012	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	5.99e-05	0.00117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KIF3A—atopic dermatitis	5.92e-05	0.00116	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	5.9e-05	0.00116	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	5.85e-05	0.00115	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	5.85e-05	0.00115	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL10—atopic dermatitis	5.75e-05	0.00113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	5.74e-05	0.00112	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL8—atopic dermatitis	5.71e-05	0.00112	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.56e-05	0.00109	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2—atopic dermatitis	5.46e-05	0.00107	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	5.44e-05	0.00107	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL6—atopic dermatitis	5.43e-05	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL11—atopic dermatitis	5.35e-05	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CMA1—atopic dermatitis	5.35e-05	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	5.26e-05	0.00103	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL10—atopic dermatitis	5.22e-05	0.00102	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	5.11e-05	0.001	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT6—atopic dermatitis	5.03e-05	0.000986	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MAPK8—atopic dermatitis	5.03e-05	0.000985	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCL5—atopic dermatitis	4.95e-05	0.00097	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL8—atopic dermatitis	4.77e-05	0.000934	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	4.76e-05	0.000932	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	4.76e-05	0.000932	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.75e-05	0.000931	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	4.64e-05	0.000908	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GLB1—atopic dermatitis	4.54e-05	0.00089	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL5—atopic dermatitis	4.49e-05	0.00088	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	4.47e-05	0.000876	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR5—atopic dermatitis	4.46e-05	0.000873	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	4.39e-05	0.000861	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR3—atopic dermatitis	4.36e-05	0.000855	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADSL—atopic dermatitis	4.36e-05	0.000854	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	4.24e-05	0.00083	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.22e-05	0.000827	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR5—atopic dermatitis	4.05e-05	0.000793	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	3.99e-05	0.000782	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	3.96e-05	0.000776	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TAC1—atopic dermatitis	3.89e-05	0.000762	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NPS—atopic dermatitis	3.89e-05	0.000762	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	3.88e-05	0.00076	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	3.81e-05	0.000747	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	3.62e-05	0.000709	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	3.6e-05	0.000705	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	3.45e-05	0.000677	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	3.45e-05	0.000677	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	3.39e-05	0.000664	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	3.21e-05	0.000629	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—atopic dermatitis	3.21e-05	0.000629	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	3.08e-05	0.000604	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	2.74e-05	0.000537	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	2.69e-05	0.000528	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	2.65e-05	0.00052	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	2.58e-05	0.000505	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	2.46e-05	0.000482	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	2.45e-05	0.00048	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.39e-05	0.000469	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	2.39e-05	0.000469	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	2.36e-05	0.000462	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	2.34e-05	0.000458	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	2.29e-05	0.000448	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	2.18e-05	0.000428	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	2.17e-05	0.000426	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	2.12e-05	0.000416	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	2.08e-05	0.000407	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	2.03e-05	0.000397	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	1.8e-05	0.000353	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.47e-05	0.000289	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	1.45e-05	0.000283	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	1.38e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	1.37e-05	0.000269	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	1.28e-05	0.000252	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	1.27e-05	0.000249	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	1.23e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	1.22e-05	0.000239	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	1.13e-05	0.000221	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	8.12e-06	0.000159	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	7.21e-06	0.000141	CbGpPWpGaD
